Cargando...
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Lasmiditan, a serotonin 5-HT(1F) receptor agonist, was effective for acute treatment of patients with migraine in a phase 3 double-blind randomized controlled study. The current study was designed to replicate these findings in a generalizable population of patients with migraine, including those wi...
Gardado en:
| Publicado en: | Brain |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6620826/ https://ncbi.nlm.nih.gov/pubmed/31132795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awz134 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|